Natco Pharma hits new high; up 80% in 2017

The stock hit a new high of Rs 1,054, up 3%, extending its 15% gain in past eight trading sessions.

Natco Pharma hit a new high of Rs 1,054, up 3% on the BSE extending its 15% gains of the last eight trading sessions after the company reported a good set of numbers for the quarter ended March 2017 (Q4FY17).

Natco Pharma registered a nearly three-fold growth in consolidated net profit at Rs 176 crore in Q4FY17 against Rs 63 crore posted in the corresponding quarter of the previous year.

The company's consolidated revenues increased 46% to Rs 577 crore in the fourth quarter under review as compared to Rs 395 crore in the year ago period.